Estimating & comparing greenhouse gas emissions for existing intramuscular COVID-19 vaccines and a novel thermostable oral vaccine
Background: Climate impacts are rarely considered in health impact and economic assessments of public health programs. This study estimates the greenhouse gas (GHG) emissions averted by a novel oral SARS-CoV-2 (COVID-19) vaccine compared with four existing intramuscular vaccines: AstraZeneca's...
Saved in:
Main Authors: | Bryan Patenaude (Author), Jeromie Ballreich (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modeling the potential economic benefits of an oral SARS-CoV-2 vaccine during an outbreak of COVID-19
by: Bryan Patenaude, et al.
Published: (2022) -
Greenhouse gas emissions due to unnecessary antibiotic prescriptions
by: Emily S. Spivak, et al.
Published: (2024) -
Pediatric telemedicine visits reduce greenhouse gas emissions
by: David F. Grabski, et al.
Published: (2024) -
Greenhouse Gas Emissions and Health in the Countries of the European Union
by: Beata Gavurova, et al.
Published: (2021) -
The power of public health officers to curb greenhouse gas emissions
by: Peter Tait, et al.
Published: (2019)